Unlock the potential of biosimilars: Improve patient access and long-term healthcare sustainability
Evvnt Promotion / evvnt
Archive
10.05.2021 Online, Germany
Time: 3:00 pm - 5:00 pm
Conference themes
Since the world’s first biosimilar was approved in 2006, these treatments have had a positive impact on patient access and healthcare system sustainability. However, despite 15 years of progress, several challenges need to be addressed in order to unlock their full potential.
Since the world’s first biosimilar was approved in 2006, these treatments have had a positive impact on patient access and healthcare system sustainability. However, despite 15 years of progress, several challenges need to be addressed in order to unlock their full potential.
Professional congress organizer (PCO)
Reuters Events
Reuters Events
Enquiries and Registration:
Mr. Josh Bramwell
General Medicine
Languages
English
English
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
